Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44 | 10 | 5 | 26 | N/A |
| Receivables | 36 | 19 | 11 | 29 | 17 |
| Inventories | 5 | 5 | 5 | N/A | N/A |
| TOTAL | $183 | $65 | $89 | $219 | $96 |
| Non-Current Assets | |||||
| PPE Net | 17 | 21 | 25 | 28 | 32 |
| Other Non-Current Assets | 16 | 16 | 16 | 19 | 25 |
| TOTAL | $33 | $37 | $41 | $47 | $57 |
| Total Assets | $216 | $101 | $129 | $266 | $153 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 996 | 1,019 | 1,359 | 1,350 | 1,086 |
| Accounts payable and accrued liabilities | 1,802 | 1,808 | 1,709 | 1,688 | 1,779 |
| Accrued Expenses | 960 | 968 | 958 | 949 | 982 |
| Other current liabilities | 393 | 250 | 323 | 848 | 17 |
| TOTAL | $4,150 | $4,045 | $4,349 | $4,835 | $3,864 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 30 | 30 | 0 | 0 | 0 |
| TOTAL | $30 | $30 | $N/A | $N/A | $N/A |
| Total Liabilities | $4,180 | $4,075 | $4,349 | $4,835 | $3,864 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,998 | 28,153 | 26,407 | 23,777 | 17,954 |
| Common Shares | 1,269 | 1,062 | 1,004 | 925 | 712 |
| Retained earnings | -43,513 | -42,194 | -41,987 | -41,373 | -38,726 |
| TOTAL | $-3,964 | $-3,973 | $-4,219 | $-4,569 | $-3,711 |
| Total Liabilities And Equity | $216 | $101 | $129 | $266 | $153 |